RABI-767
/ Panafina
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
October 08, 2025
A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis
(clinicaltrials.gov)
- P2 | N=36 | Recruiting | Sponsor: Panafina, Inc. | Trial primary completion date: Dec 2025 ➔ Mar 2026
Trial primary completion date • Pancreatitis
February 21, 2025
A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis
(clinicaltrials.gov)
- P2 | N=36 | Recruiting | Sponsor: Panafina, Inc. | Trial completion date: Oct 2025 ➔ Feb 2026
Trial completion date • Pancreatitis
October 29, 2024
A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis
(clinicaltrials.gov)
- P2 | N=36 | Recruiting | Sponsor: Panafina, Inc. | Trial completion date: Feb 2025 ➔ Oct 2025 | Trial primary completion date: Feb 2025 ➔ Oct 2025
Trial completion date • Trial primary completion date • Pancreatitis
August 06, 2024
A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis
(clinicaltrials.gov)
- P2 | N=36 | Recruiting | Sponsor: Panafina, Inc. | Initiation date: Feb 2024 ➔ Jun 2024
Trial initiation date • Pancreatitis
1 to 4
Of
4
Go to page
1